(Q36342592)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16356023%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

review article

1 reference

title

Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16356023%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16356023%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Stefan Zielen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16356023%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16356023%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16356023%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16356023%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16356023%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

353-363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16356023%20AND%20SRC:MED&resulttype=core&format=json

Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis

10 January 2020

cites work

1 reference

12 December 2020

A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis

1 reference

12 December 2020

Cystic fibrosis: pathogenesis, pulmonary infection, and treatment

1 reference

12 December 2020

Atopic children with cystic fibrosis have increased urinary leukotriene E4 concentrations and more severe pulmonary disease

1 reference

12 December 2020

Airways reactivity in patients with CF.

1 reference

12 December 2020

Leukotriene B4 in inflammation.

1 reference

12 December 2020

Relationship between disease severity and inflammatory markers in cystic fibrosis

1 reference

12 December 2020

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

1 reference

12 December 2020

Stimulation of matrix metalloproteinase‐dependent migration of T cells by eicosanoids

1 reference

12 December 2020

Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease

1 reference

12 December 2020

Eosinophilic activation in cystic fibrosis

1 reference

12 December 2020

Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro

1 reference

12 December 2020

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

1 reference

12 December 2020

Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis

1 reference

12 December 2020

Liberation of histamine and formation of lysocithin-like substances by cobra venom

1 reference

12 December 2020

Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis

1 reference

12 December 2020

Identification of interferon-gamma as the lymphokine that mediates leukotriene B4-induced immunoregulation

1 reference

12 December 2020

Effects of short-term inhaled fluticasone on oxidative burst of sputum cells in cystic fibrosis patients

1 reference

12 December 2020

Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist

1 reference

12 December 2020

The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air

1 reference

12 December 2020

Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4

1 reference

12 December 2020

Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect

1 reference

12 December 2020

The role of inflammation in the pathophysiology of CF lung disease

1 reference

12 December 2020

Determination of leukotriene effects on human neutrophil chemotaxis in vitro by differential assessment of cell motility and polarity.

1 reference

12 December 2020

Leukotriene- and Histamine-Induced Increases in Vascular Permeability and Interstitial Transport in the Skin

1 reference

12 December 2020

Differential stimulation of cytosolic phospholipase A2 by bradykinin in human cystic fibrosis cell lines

1 reference

12 December 2020

Cystic Fibrosis Gene Mutation (ΔF508) Is Associated with an Intrinsic Abnormality in Ca2+-Induced Arachidonic Acid Release by Epithelial Cells

1 reference

12 December 2020

Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.

1 reference

12 December 2020

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

1 reference

12 December 2020

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

1 reference

12 December 2020

Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies

1 reference

12 December 2020

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

1 reference

12 December 2020

Vascular effects of leukotriene D4 in human skin

1 reference

12 December 2020

Anti-inflammatory effects of montelukast in mild cystic fibrosis.

1 reference

12 December 2020

Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4

1 reference

12 December 2020

SRS-A leukotrienes decrease the activity of human respiratory cilia

1 reference

12 December 2020

Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic BronchopulmonaryPseudomonas aeruginosaInfection

1 reference

12 December 2020

Effect of pranlukast on bronchial inflammation in patients with asthma

1 reference

12 December 2020

Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.

1 reference

12 December 2020

The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma

1 reference

12 December 2020

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

12 December 2020

Sputum cysteinyl‐leukotriene levels correlate with the severity of pulmonary disease in children with cystic fibrosis

1 reference

12 December 2020

The formation of lysocithin and of a muscle-stimulating substance by snake venoms

1 reference

12 December 2020

Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis

1 reference

12 December 2020

Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy.

1 reference

12 December 2020

Wheezing and airflow obstruction during methacholine challenge in children with cystic fibrosis and in normal children

1 reference

12 December 2020

Signal transduction processes for the LTD4 receptor

1 reference

12 December 2020

Enhanced hepatic drug clearance in patients with cystic fibrosis

1 reference

12 December 2020

A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis

1 reference

12 December 2020

Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages

1 reference

12 December 2020

IDENTIFICATION OF LEUKOTRIENES D AND B IN SPUTUM FROM CYSTIC FIBROSIS PATIENTS

1 reference

12 December 2020

Montelukast pharmacokinetics in cystic fibrosis

1 reference

12 December 2020

Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism

1 reference

12 December 2020

Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis

1 reference

12 December 2020

The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease

1 reference

12 December 2020

Role of leukotrienes in asthma pathophysiology

1 reference

12 December 2020

The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).

1 reference

12 December 2020

Inflammation and infection in naive human cystic fibrosis airway grafts

1 reference

12 December 2020

Leukotrienes C4, D4, and E4 enhance histamine responsiveness in asthmatic airways.

1 reference

12 December 2020

Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis

1 reference

12 December 2020

Novel pathways in the pathogenesis of respiratory syncytial virus disease

1 reference

12 December 2020

The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 typeNote

1 reference

12 December 2020

Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma

1 reference

12 December 2020

Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease

1 reference

12 December 2020

Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis

1 reference

12 December 2020

Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis

1 reference

12 December 2020

Leukotrienes in the sputum and urine of cystic fibrosis children

1 reference

12 December 2020

Correlation between spontaneous oscillations of cytosolic free Ca2+ and tumor necrosis factor-induced degranulation in adherent human neutrophils

1 reference

12 December 2020

Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis

1 reference

12 December 2020

Airway hyperreactivity in cystic fibrosis. Clinical correlates and possible effects on the course of the disease

1 reference

12 December 2020

In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist.

1 reference

12 December 2020

Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis

1 reference

12 December 2020